Le Lézard
Classified in: Health
Subject: SVY

Synthetaic is Developing a Real Time Tumor Classification System


DUBLIN, Oct. 27, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the AI industry "Synthetaic is Developing a Real Time Tumor Classification System"

Research and Markets Logo

Synthetaic announced it has raised $3.5 million in a funding round led by Lupa Systems, with participation from Betaworks Ventures and TitletownTech (a partnership between Microsoft and the Green Bay Packers). The funding will enable Synthetaic to grow its team and scale its modeling and generative artificial intelligence technologies as well as supporting strategic technology partnerships. Synthetaic's technology combines high-fidelity 3D models with novel, generative AI technologies to grow large datasets of synthetic images for machine learning.

The company produces photorealistic models and then uses adversarial networks to generate hundreds of thousands of images displaying the model against different backgrounds. After an AI has been trained on the synthesized images, the results are validated by testing the AI on real data. In collaboration with the University of Michigan, Synthetaic is developing a real time tumor classification system to assist surgeons in identifying types of brain cancer while performing surgery. The company has also partnered with Save the Elephants to use the technology to track animal populations.

To see the full article and a list of related reports on the market, visit "Synthetaic is Developing a Real Time Tumor Classification System"

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:35
Agenus Inc. ("Agenus") , a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Agenus executives...

at 07:34
Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An," the "Company" or the "Group," HKEX: 2318; SSE: 601318) today announced its first quarter financial results for the three months ended March 31, 2024....

at 07:31
Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology, announced today an option agreement for an...

at 07:30
KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh. This forum aims to discuss the primary healthcare challenges facing the...

at 07:30
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on...

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....



News published on and distributed by: